Professional Activities:

Awards

  • 138 Publications from Academic and Industrial R&D
  • 13 PhD or MS Graduate Students advised or co-advised
  • Courses Taught (Immunology, Clinical Immunology, Selected Executive MBA classes, Honors Seminar)
  • Taught Freshman Honors class in “Food Frontiers” 2001 and 2004.
  • Taught Freshman Seminar in 2011 class called “Food, Genomics and Geopolitics”
  • Past/Present Professional Society Memberships
    • American Society for Clinical Oncology,
    • American Association for Cancer Research,
    • Association of University Technology Managers,
    • Licensing Executives Society,
    • American Association for the Advancement of Science,
    • American Association of Immunologists
    • Minnesota FFA (formerly Future Farmers of America) Hall of Fame 2004

Private Industrial Experience                                                                                             

  • CureiumTherapeutics, LLC, Chief Manager Consultant – 2011 to present
  • TransD, LLC (a transdermal Vitamin D company) – 2010 to present
  • Helped start one of the world’s first Biotechnology Companies, “Molecular Genetics, Inc”. – 1980-1999
  • Helped start one of Europe’s first AgBiotech Companies,  “MOGN Int. b.v”, Leiden, The Netherlands - 1985
  • Developed first US Animal Health Biotechnology Monoclonal Antibody Product (Genecol 99 monoclonal antibody) – USDA Approved 1984. Marketed 1984.
  • Key Role in development of US first Plant Biotechnology Product – Herbicide resistant corn (Imidazolinone resistance) launched 1993
  • Key Role in development of Lyme disease vaccine for pets – Launched 1990
  • Developed two FDA approved drugs – Launched 1994 & 1998 (oral pilocarpineHCl for Head and Neck Cancer Patients and same drug for Sjogrens Syndrome in rheumatology patients)
  • 35 corporate and/or academic business/technology partnerships (including Japanese and European Companies)
  • Key Role in 6 Public stock offerings (>$80 million), several private placements & key role in 5 Joint R&D Partnerships

Corporate Board Of Directors Positions / Other Advisory Boards

  • Cureium Holdings, Inc Board of Directors 2011 to present. Pharmaceutical and Dietary supplements.
  • Access Genetics, Inc. Human Molecular Diagnostic Testing. Board of Directors – 2003 to 2007
  • Burrill& Company, Inc. San Francisco, CA. Venture Capital Fund, Scientific Nutraceutical Advisory Board 2000-2008
  • Chromatin Inc.  Developing plant artificial chromosomes. Board Member –  2002-2008
  • Sciona, Inc.  Science-Based Nutrigenomic Diagnostic Tools for Personalized Diet and Medicine, Scientific Advisory Board, 2005 to 2009
  • MNBio (Medical Alley, Inc; Minnesota biotech industry advocacy group), Board member – 1999-2006
  • Sota Tec Fund, St. Paul, MN. Venture Capital Fund – Board of Directors – 2000-2007
  • Biovirx, Inc. Rotavirus vaccine company, Board of Directors, 2000 – 2006
  • Center for Technological Leadership Board of Directors, University of Minnesota – 2000-2003
  • Humanetics Corporation (dietary supplements/nutraceuticals), Chairman of the Board  – 1996-1999
  • Blizzard Genomics, Inc. Scientific Advisory Board – 2001-2003
  • Ovation Pharmaceuticals, Inc. Chicago, IL. Specialty Oncology Scientific Advisory Board – 2001-2003.
  • Applied Phytologics, Inc.  Senior Scientific Consultant for developing foods with iron lactoferrin protein therapy.  2001 - 2003
  • Technology Transfer Advisory Committee, Univ of MnAdv Board; Healthcare & Biotech –2000-2003
  • Minnesota Academy of Sciences – Board Member – 1998–2001
  • Previous consultant to American Cyanamid, Inc and General Mills, Inc.

Charles C. Muscoplat

Professor

 

  • : 612-624-5387

  • DEPARTMENTDepartment of Food Science and Nutrition
    University of Minnesota
  • COUNTRY USA